Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07037238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 5, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. 2 versions Re-verified since Jun 26, 2025, no change to tracked fieldsv2-v3
  2. Study First Submitted
This study is a single-arm exploratory trial conducted by Xuanwu Hospital, Capital Medical University, aiming to evaluate the efficacy and safety of everolimus monotherapy in adult patients with vascular malformations.
Trial Details
NCT Number NCT07037238
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
(from sponsor)		 Vascular Malformations
Related terms Vascular Malformations
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov